Aller au contenuAller au pied de page
      employer cover photo
      employer logo
      employer logo

      Merck

      Est-ce votre entreprise ?

      Avis sur Merck

      Turning from a science driven company to a people driven one - Avis employé Senior Scientist Merck

      4,0
      22 nov. 2017
      Senior scientist
      Recommande
      Approbation du PDG
      Perspective commerciale

      Avantages

      Lots of training/learning opportunities (rotation program is awesome), especailly for new grads. You can easily find experts in that field if you want to learn things. Colleagues are in general nice and helpful. Competitive compensation, pension plan (rare in the industry nowadays), educational assistance (only $5250/year though), paid paternity leave (dads as well), flexible working hours etc.

      Inconvénients

      Culture going downhill quickly. Science used to the top priority but not anymore. A lot of managers are scientifically mediocre while senior/experienced scientists have no direct report. Can you believe R&D directors only hold a bachelor degree? Career opportunities are fairly limited.

      Découvrez plus d’avis sur Merck

      5,0
      30 juin 2026
      Business analyst
      Recommande
      Approbation du PDG
      Perspective commerciale

      Avantages

      Excellent company to work with.

      Inconvénients

      No cons encountered so far

      4,0
      30 juin 2026
      Senior scientist i
      Recommande
      Approbation du PDG
      Perspective commerciale

      Avantages

      Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

      Inconvénients

      Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

      Voir les avis par: Utile|Évaluation|Date|Tout
      Recherches associées: Offres d’emploi chez Merck | Salaires chez Merck | Avantages sociaux chez Merck | Entretiens chez Merck
      Avis sur MerckAvis pour Senior Scientist chez MerckAvis sur Merck